| Trial ID: | L6069 |
| Source ID: | NCT00885638
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00885638/results
|
| Conditions: |
Healthy|Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin|DRUG: placebo
|
| Outcome Measures: |
Primary: Glucagon-like Peptide-1 Secretion After Meal Ingestion, Plasma GLP-1 levels will be measured during 300 min after meal ingestion for estimation of GLP-1 secretion, 300 min | Secondary: Insulin Secretion After Ingestion of Meal, Plasma insulin levels will be measured during 300 min after meal ingestion to estimation of insulin secretion, 300 min
|
| Sponsor/Collaborators: |
Sponsor: Lund University
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2009-08
|
| Completion Date: |
2012-09
|
| Results First Posted: |
2013-01-15
|
| Last Update Posted: |
2014-01-30
|
| Locations: |
Department of Clinical Sciences Lund, Lund University, Lund, 221 84, Sweden
|
| URL: |
https://clinicaltrials.gov/show/NCT00885638
|
